Cevac Vitapest L

Cevac Vitapest L. Description CEVAC™ MD HVT Marek’s disease vaccine contains serotype 3 (herpesvirus of turkeys or HVT) Marek’s disease virus This vaccine is recommended for use in chickens as an aid in the prevention of Marek’s disease This Marek’s disease vaccine containing serotype 3 is presented in a frozen cell associated form.

CEVAC ® VITAPEST L CEVAC ® UNI L CEVAC ® NEW L Infectious bronchitis CEVAC ® IBIRD CEVAC ® MASS L CEVAC ® BRON 120L Newcastle disease & Infectious Bronchitis CEVAC ® VITABRON L CEVAC ® BI L CEVAC ® NB L Salmonella CEVAC ® SG9R CEVA ® Salmovac 440 Chicken Infectious Anemia CIRCOMUNE ® Mycoplasma gallisepticum CEVAC ® MGF.

Shape The Poultry Site Your poultry knowledge hub

Specificpathogenfree chicks were vaccinated intraocularly at 1 day of age with one dose of Cevac Vitapest L containing the NDV strain PHYLMV42 (CEVAPhylaxia) Organ (brain conjunctiva trachea lung and cecal tonsil) and swab (oral and cloacal) samples were taken at days 2 5 and 9 postvaccination (pv).

Cevac MD HVT for Animal Use Drugs.com

Elucidation of HI antibody titers of group D birds receiving Cevac VitapestL® on same days were recorded to be of Mean ± SD of 9600 ± 3373 11520 ± 2698 and 32000 ± 17331 at 15 (10 DPV) 19 (14 DPV) and 31 (26 DPV) days of age respectively.

RealTime PCRBased Pathotyping of Newcastle Disease Virus

CEVAC ® VITAPEST L contains the PHYLMV42 apathogenic strain of Newcastle Disease virus in live freezedried form The embryonated hen eggs used in the production of the vaccine are obtained from specifiedpathogenfree (SPF) flocks INDICATIONS For the active immunisation of healthy chickens against Newcastle Disease.